About Qingmu Pharm
Qingmu Pharm is a leading China-based API and intermediate supplier with over 12 years of industry experience. As a innovator-driven company, they focus on developing and manufacturing APIs using green chemistry principles. Their R&D team has extensive expertise in organic synthesis including areas like asymmetric catalysis highly applicable to producing ruxolitinib API at scale.
Dedication to Quality
Qingmu Pharm's facilities meet cGMP standards and are regularly audited by global regulatory bodies like the FDA and EMA. They implement stringent quality controls throughout production to ensure ruxolitinib phosphate API batches consistently meet purity specifications.
Proven Track Record
As a leading API provider, Qingmu Pharm has delivered commercial quantities of ruxolitinib API to multiple regions for use in marketed generics and formulations. Their on-time delivery rating exceeds 99%.
Technical Support
The company offers full technical documentation and can provide reference standards, impurity profiles and advisory support to assist customers. Stability studies demonstrate their API maintains quality over time.
Competitive Pricing
By leveraging established production processes and economies of scale, Qingmu Pharm provides ruxolitinib phosphate API and custom synthesis services at competitive prices.
In summary, Qingmu Pharm stands out as a premier supplier of ruxolitinib phosphate API and related services worldwide due to their strong track record of quality, reliability and industry expertise.
Comments (0)